Biotech With a strong research base formed around the Karolinska Institute and Uppsala University, Sweden has grown to be one of Europe’s premier biotech hotspots. Several companies spun out of research conducted at these institutes and others are now listed on the Stockholm stock exchange and already have products on the…
Sweden Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned internationally for its quality and high technology. The Swedish healthcare and life sciences sector enjoys a good reputation abroad and is strongly associated with quality and innovation…
France The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a closer look at the wider French life sciences value chain and the spirit of innovation and reform sweeping the nation. A reform-minded and business-oriented administration under President Emmanuel Macron…
Sweden Sweden’s comprehensive and high-quality system of electronic health records is increasingly in demand from international researchers in the machine learning and AI fields and is also facilitating significant breakthroughs in more traditional medical research. The Swedish National Patient Register (NPR) contains comprehensive lists of data sorted into four groups:…
Spain Esteve has long been a family-run business, though in early 2018 the Spanish champion decided to make a daring, though calculated, move and positioned the then CCO of Lundbeck, Staffan Schüberg, as their new CEO. We have world-class experience [in neuroscience and gene therapy] and we see these areas…
France Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world pharmaceuticals stage. Privately owned, smaller and sleeker than many of its direct competitors, but nonetheless formidably successful, Servier has, for many years, been characterized by its discreet, understated approach and a rugged pragmatism and…
Switzerland In view of the manifold hurdles encountered when attempting to raise capital, Switzerland’s medium capitalized entities and SMEs have grown adept at punching well above their weight. After the giants, Roche and Novartis, some of the larger companies in the Swiss pharma sector like Ferring and IBSA are privately held,…
Spain Despite the Spanish economy and pharmaceutical market’s steady growth, many local players are becoming cognizant of the limitations and risks of operating within a single market. Therefore, these small to mid-cap local companies are taking the next logical steps in their growth; internationalization. The financial crisis in 2008 pushed…
France Iconic French skincare specialist, Pierre Fabre has been enjoying a hot streak of late, with its dermo-cosmetics business registering hefty sales growth of more than EUR 350 (USD 392) million since 2014. It is, however, the company’s unique positioning right at the confluence between the worlds of medicines and cosmetics…
Sweden Gothenburg-headquartered Cellink has gone from a start-up to one of the world’s leading 3D bioprinting firms in just four years; firmly positioning Sweden at the forefront of this potentially revolutionary new technology. In the coming decade we would like to continue to push the boundaries of 3D bioprinting until…
Spain With cost pressures mounting, Spain is increasingly turning towards digital solutions to maintain the high levels of care provided by its healthcare system. Spain is at a point of disruption in which the healthcare system is facing big challenges; the solution to which has to be technology Angeles Delgado,…
UK Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial asset on the market, a strong pipeline of development assets and a commercial infrastructure across the EMEA region already in place, the company is aiming to expand rapidly. We have expanded…
See our Cookie Privacy Policy Here